SH-SS and GSH-GSSG Homeostasis in Post-stroke Patients
Association of Extracellular Thiol-disulfide and Intracellular Oxidized-reduced Glutathione Homeostasis With Severity and Clinical Prognosis of Post-stroke Patients
1 other identifier
observational
77
1 country
1
Brief Summary
In patients undergoing physical therapy after stroke, extracellular thiol-disulfide balance and intracellular oxidized-reduced glutathione balance levels will be monitored. The main objectives of this study are; (1) to determine the differences between thiol-disulfide and GSH-GSSG balances in stroke patients compared to healthy volunteers, (2) to evaluate the relationship of these balances with the severity of stroke, (3) to determine the predictive value of the levels of these balances on clinical prognosis and functional recovery outcomes, and (4) to investigate and to examine the effects of the physical therapy process on these parameters and functional recovery and their relationship with each other.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2021
CompletedFirst Submitted
Initial submission to the registry
April 21, 2021
CompletedFirst Posted
Study publicly available on registry
May 13, 2021
CompletedMay 13, 2021
May 1, 2021
6 months
April 21, 2021
May 7, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
NIHSS Scores
National Institutes Of Health Stroke Scale Scores
at baseline (pre-treatment)
NIHSS Scores
National Institutes Of Health Stroke Scale Scores
after 4 weeks of treatment (post-treatment)
mRS
modified Rankin Scales
at baseline (pre-treatment)
mRS
modified Rankin Scales
after 4 weeks of treatment (post-treatment)
BI
Barthel Index for Activities of Daily Living
at baseline (pre-treatment)
BI
Barthel Index for Activities of Daily Living
after 4 weeks of treatment (post-treatment)
Study Arms (2)
post-stroke patient
patients with subacute stroke who have a stroke for the first time and admitted to the hospital for the first rehabilitation treatments
Control
healthy volunteers who have not got any known disease and any sign in physical examination
Interventions
Monitoring the levels of thiol and disulphide in serum
Monitoring the levels of intracellular oxidized glutathione and reduced glutathione in whole blood samples
Eligibility Criteria
Post-stroke patients group admitted to hospital to take rehablititation and physiotherapy within 1 to 6 months of stroke onset. Healthy adult volunteers (control) group (\> 18 years of age) with no known disease and no findings on physical examination
You may qualify if:
- diagnosis of a first-ever stroke verified by computed tomography (CT) or magnetic resonance imaging (MRI) reports
- admitted to the hospital for standard neurorehabilitation within 1 to 6 months of stroke onset
- healthy individuals (for control group)
You may not qualify if:
- significant acute medical illness (e.g., autoimmune disease, infection, tumor, heart failure, renal or liver dysfunction)
- significant acute neurological illness other than stroke (e.g., head trauma, brain abscess, brain tumor, migraine attack, seizure)
- cannot adapt to work
- previous history of neurorehabilitation therapy
- taking the antioxidant supplements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bolu Abant Izzet Baysal University
Bolu, Turkey (Türkiye)
Related Publications (5)
Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989 Jul;20(7):864-70. doi: 10.1161/01.str.20.7.864.
PMID: 2749846BACKGROUNDKucukdeveci AA, Yavuzer G, Tennant A, Suldur N, Sonel B, Arasil T. Adaptation of the modified Barthel Index for use in physical medicine and rehabilitation in Turkey. Scand J Rehabil Med. 2000 Jun;32(2):87-92.
PMID: 10853723BACKGROUNDBroderick JP, Adeoye O, Elm J. Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials. Stroke. 2017 Jul;48(7):2007-2012. doi: 10.1161/STROKEAHA.117.017866. Epub 2017 Jun 16. No abstract available.
PMID: 28626052BACKGROUNDErel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014 Dec;47(18):326-32. doi: 10.1016/j.clinbiochem.2014.09.026. Epub 2014 Oct 7.
PMID: 25304913BACKGROUNDAlisik, M., Neselioglu, S., & Erel, O. (2019). A colorimetric method to measure oxidized, reduced and total glutathione levels in erythrocytes, Journal of Laboratory Medicine, 43(5), 269-277
BACKGROUND
Biospecimen
Serum and whole blood samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tugba Alisik, MD
Abant Izzet Baysal University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 21, 2021
First Posted
May 13, 2021
Study Start
July 1, 2020
Primary Completion
January 1, 2021
Study Completion
January 31, 2021
Last Updated
May 13, 2021
Record last verified: 2021-05